As Reported in Tech Crunch. Everlywell was one of the first startups to announce that it was working on a self-administered, at-home COVID-19 diagnostic kit, but it initially sought out to ship kits before regulators made clear that this was not in line with its guidelines. Everlywell then became intent on working with the FDA to secure a proper Emergency Use Authorization for its kits before sending any to consumers, and that approach has paid off with the U.S. drug regulator issuing an EUA for Everlywell’s tech today. Everlywell‘s COVID-19 Test Home Collection Kit is the first standalone sample collection…
Author: Brett Johnson
Hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 according Henry Ford Health System. Of 2,541 patients hospitalized between March 10 and May 2, 2020 the study found 13% of those treated with hydroxychloroquine died compared to 26.4% not treated with hydroxychloroquine. The study was published today in the International Journal of Infectious Diseases. “using hydroxychloroquine helped save lives,” said neurosurgeon Dr. Steven Kalkanis, CEO, Henry Ford Medical Group. “As doctors and scientists, we look to the data for insight. And the data here is clear that there was benefit to using the drug as a treatment…
In the May 27 issue of the American Journal of Epidemiology, Dr. Harvey A. Risch concluded that Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis. More than 1.6 million Americans have been infected with SARS-CoV-2 and >10 times that number carry antibodies to it. High-risk patients presenting with progressing symptomatic disease have only hospitalization treatment with its high mortality. An outpatient treatment that prevents hospitalization is desperately needed. Two candidate medications have been widely discussed: remdesivir, and hydroxychloroquine+azithromycin. Remdesivir has shown mild effectiveness in hospitalized inpatients, but no trials…
Sanofi and Luminostics to develop COVID-19 smartphone-based self-testing solution Sanofi and Luminostics to join forces on developing breakthrough COVID-19 smartphone-based self-testing solution using Luminostics’ innovative technology. a smartphone-based solution that eliminates the current need for healthcare professional administration or laboratory tests. A self-testing could help providemwhether or not they are infected” with respiratory samples in 30 minutes or less. The system involves smartphone’s optics, controlled by an iOS/Android app paired with an inexpensive adapter. It is combination with “glow-in-the-dark” nanochemistry and signal processing artificial intelligence. The diagnostic platform is composed of: an iOS/Android app to instruct a user on how…
A diagnostic test as simple to use as a pregnancy test. Researchers at the Broad Institute in Cambridge, Mass. announced in early May a prototype of a quick and inexpensive test for the coronarvirus, at around $6, they hope. This could overcome the shortcomings of the PCR Test. Dr. Feng Zhang and his colleagues posted a description of their device on the website STOPCovid dedicated to their project which. Dr. Zhang and his colleagues hope to fill that gap with tests that are affordable and easy enough to use without special expertise, according to The New York Times, which first…
A private Florida company, Healthe Lighting is offering a system to disinfecting people who walk through a framed doorway that uses Ultra Violet light. The cleansing takes about as long as going a scan at the airport. For UVC light is a lower spectrum of UV light that can isn’t harmful to humans that was recently developed at Columbia University and holds great promise to kill airborne pathogens such as the COVID-19. See related story entitled: Far UVC Light Kills Airborne Viruses that describes a technology developed at Columbia University. Fox news reporter Liz Clayman. Interviews the co-founder and Chief…
Intelligent strategy depends on quality information. The Virus Project is committed to deep understanding on all aspects of the pandemic. We are seeking specific information about those who have succumbed to the disease by getting detailed information as possible. We’re seeking to collect for a two or three day period during the midst data on the following. We expect this to number approximately 400 records. Age. Sex. Underlying conditions. (diabetic, high blood pressure) Occupation. Source of income. Number of dependents. Head of household. Residence. (live alone, with family, single family home, nursing home, apartment, shelter, etc.) Zip code. Suspected source…
The development of a UVC light technology at Columbia could be breakthrough in curtailing spread of COVID-19 in indoor public places. The technology, developed by Columbia University’s Center for Radiological Research, uses lamps that emit continuous, low doses of a particular wavelength of ultraviolet light, known as far-UVC, which can kill viruses and bacteria without harming human skin, eyes and other tissues, as is the problem with conventional UV light. It can be safely used in occupied public spaces, and it kills pathogens in the air before people breathe them in. Scientists have known for decades that germicidal UV light…